DIGNITY HEALTH
SAN FRANCISCO, California
Total Received
$151.7M
Total Awards
52
State
California
Last Updated
Mar 26, 2026
Yearly Funding Trend
$143.7M24
$8.0M25
Top 50 Awards to DIGNITY HEALTH
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 26, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_OT2NS136939_075 ACCESS FOR ALL IN ALS (ALL ALS) WEST CLINICAL COORDINATING CENTER - ” AMYOTROPHIC LATERAL SCLEROSIS (ALS) IS A RAPIDLY PROGRESSIVE, ULTIMATELY FATAL, NEURODEGENERATIVE DISEASE WIT… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | AZ-90 | 2024 | $51,203,440 |
ASST_NON_P01AG014449_075 NEUROBIOLOGY OF MILD COGNITIVE IMPAIRMENT IN THE ELDERLY - OVERALL PROGRAM SUMMARY/ABSTRACT ALZHEIMER’S DISEASE (AD) IS A DEVASTATING PROGRESSIVE NEURODEGENERATIVE DISORDER AFFECT… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | AZ-90 | 2024 | $30,356,642 |
ASST_NON_W81XWH1710429_097 PATHOGENESIS OF VASCULAR MALFORMATIONS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA: FROM DISEASE MECHANISM TO NEW THERAPIES EXTEND THE PERIOD OF PERFORMANCE 1. PER SECTION 711 OF THE… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2024 | $9,933,291 |
ASST_NON_R01ES021488_075 IMAGING BIOMARKERS OF NEUROTOXICITY IN WELDERS - ABSTRACT MANGANESE (MN) IS AN ESTABLISHED NEUROTOXICANT THAT AFFECTS THE SAME MOTOR AND COGNITIVE BRAIN PATHWAYS AFFECTED IN PARKI… | Department of Health and Human Services National Institutes of Health | 93.113 ENVIRONMENTAL HEALTH | AZ-90 | 2024 | $5,267,495 |
ASST_NON_R01NS120331_075 MICROGLIA CONTRIBUTION TO DISEASE PATHOGENESIS IN C9ORF72 ALS/FTD - PROJECT ABSTRACT THE ROLE OF MICROGLIA IN THE C9ORF72 (C9) AMYOTROPHIC LATERAL SCLEROSIS (ALS)/ FRONTOTEMPORAL… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | AZ-90 | 2024 | $4,229,195 |
ASST_NON_R01ES029524_075 NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESENEUROTOXICITY - MANGANESE (MN) IS AN ESTABLISHED NEUROTOXICANT THAT CAUSES PARKINSONISM AND COGNITIVE IMPAIRMENT WITH FEATURE… | Department of Health and Human Services National Institutes of Health | 93.113 ENVIRONMENTAL HEALTH | AZ-90 | 2024 | $2,801,748 |
ASST_NON_R01NS115815_075 A TRANSLATIONAL EVALUATION OF SUR1-TRPM4 IMAGING ENDOPHENOTYPES AND GENETICS TO DIRECT PRECISION MEDICINE FOR CEREBRAL EDEMA AFTER TRAUMATIC BRAIN INJURY - FOR DECADES, THERE HAS… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | PHOENIX, AZ-03 | 2024 | $2,799,271 |
ASST_NON_R01AG077780_075 ROLES OF AGING AND CELLULAR SENESCENCE IN THE DEVELOPMENT OF INTRACRANIAL ANEURYSM RUPTURE - PROJECT SUMMARY CLINICAL STUDIES HAVE CONSISTENTLY SHOWN A STRONG ASSOCIATION BETWEEN… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | PHOENIX, AZ-03 | 2024 | $2,423,789 |
ASST_NON_R01AG059008_075 MCLENA-1: A CLINICAL TRIAL FOR THE ASSESSMENT OF LENALIDOMIDE IN AMNESTIC MCI PATIENTS - ABSTRACT THE VAST MAJORITY OF THERAPEUTIC INTERVENTIONS TARGETING ALZHEIMER'S DISEASE (AD)… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | AZ-90 | 2024 | $2,209,288 |
ASST_NON_R01DK108798_075 ALPHA-SYNUCLEIN AGGREGATION DISRUPTS MOTILITY, SYNAPTIC TRANSMISSION, AND CALCIUM SIGNALING IN THE MYENTERIC PLEXUS OF THE RAT COLON - PROJECT SUMMARY/ABSTRACT PARKINSON'S DISEASE… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | PHOENIX, AZ-03 | 2024 | $2,114,745 |
ASST_NON_R01AG073212_075 REPURPOSING SIPONIMOD FOR ALZHEIMER'S DISEASE - SUMMARY/ABSTRACT REPURPOSING SIPONIMOD FOR ALZHEIMER’S DISEASE ALZHEIMER’S DISEASE (AD) IS A NEURODEGENERATIVE DISORDER WITH SEVERA… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | AZ-90 | 2024 | $2,107,816 |
ASST_NON_DP2DK128802_075 HYPOTHALAMIC NEUROCIRCUIT REMODELING TO TREAT DIABETES - PROJECT SUMMARY DIABETES AFFLICTS OVER 30 MILLION AMERICANS, CORRESPONDING TO NEARLY 10% OF THE GENERAL POPULATION AND ACC… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | AZ-90 | 2025 | $2,078,306 |
ASST_NON_R01NS124575_075 MULTI-SCALE FUNCTIONAL CONNECTIVITY IN PRECLINICAL MODELS OF PARKINSON'S DISEASE - PROJECT SUMMARY / ABSTRACT: PARKINSON’S DISEASE IS A PROGRESSIVE NEURODEGENERATIVE DISORDER AND… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | PHOENIX, AZ-03 | 2024 | $1,944,981 |
ASST_NON_R01NS109584_075 MECHANISMS FOR INTRACRANIAL ANEURYSM RUPTURE - PROJECT SUMMARY POTENTIAL ROLES OF NEUTROPHILS AND PLATELETS IN THE PATHOPHYSIOLOGY OF INTRACRANIAL ANEURYSMS HAVE BEEN LONG SUGGEST… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | PHOENIX, AZ-03 | 2024 | $1,925,032 |
ASST_NON_W81XWH2010250_097 PLASTICITY AND NEUROCIRCUIT REMODELING IN THE MEDIOBASAL HYPOTHALAMUS TO TREAT DIABETES EXTEND THE PERIOD OF PERFORMANCE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2024 | $1,739,853 |
ASST_NON_R01NS097821_075 QUANTITATIVE ASSESSMENT OF PERIPHERAL NERVE INJURY AND REPAIR VIA MULTI-PARAMETRIC MRI - PROJECT SUMMARY THE OVERALL GOAL OF THIS PROPOSAL IS TO DEVELOP AND EVALUATE A MULTI-PARA… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | PHOENIX, AZ-03 | 2024 | $1,718,622 |
ASST_NON_R01AG057708_075 PATHWAYS LINKING NEUROPSYCHIATRIC SYMPTOMS WITH ALZHEIMER'S DISEASE NEUROIMAGING BIOMARKERS AND THE OUTCOME OF INCIDENT MILD COGNITIVE IMPAIRMENT/ DEMENTIA - PROJECT SUMMARY PATHO… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | AZ-90 | 2024 | $1,652,964 |
ASST_NON_R01HL156891_075 CHRONIC LUNG ALLOGRAFT DYSFUNCTION: ROLE FOR TUMOR SUPPRESSOR LKB1 IN EXOSOMES - PROJECT SUMMARY/ABSTRACT LUNG TRANSPLANTATION (LTX) IS A THERAPEUTIC OPTION FOR PATIENTS WITH ADVA… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | PHOENIX, AZ-03 | 2024 | $1,649,563 |
ASST_NON_W81XWH2210483_097 MRI BIOMARKERS OF TRAUMATIC PERIPHERAL NERVE INJURY AND REPAIR: VALIDATION AND MULTISITE APPLICATION ADD INCLUSION ENROLLMENT REPORT TERM REMOVE PAYMENT RESTRICTION CLAUSE OHRO HU… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2025 | $1,628,512 |
ASST_NON_R61NS127268_075 DIFFUSION MRI BIOMARKERS OF PERIPHERAL NERVE TRAUMA - PROJECT SUMMARY PERIPHERAL NERVE DAMAGE FOLLOWING TRAUMA RESULTS IN CATASTROPHIC LOSS OF SENSORIMOTOR FUNCTION IF NOT TREATED… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | AZ-90 | 2024 | $1,622,655 |
ASST_NON_R01AG089239_075 AN INTEGRATIVE COMPUTATIONAL MULTIMODAL APPROACH TO DISENTANGLE PATHOPHYSIOLOGIC HETEROGENEITY OF AGE-RELATED WHITE MATTER HYPERINTENSITIES - ABSTRACT WHITE MATTER HYPERINTENSITI… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | AZ-90 | 2024 | $1,585,301 |
ASST_NON_U24NS107204_075 BARROW NEUROLOGICAL INSTITUTE APPLICATION TO BECOME A NEURONEXT SITE. - THIS APPLICATION FROM THE BNI (BNI) RESPONDS TO THE NINDS PA TO PARTICIPATE AS A CLINICAL SITE IN THE NETWO… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | AZ-90 | 2025 | $1,504,982 |
ASST_NON_HT94252410464_097 A NOVEL BIFUNCTIONAL AGENT AS A RADIOSENSITIZER FOR GLIOBLASTOMA AND RADIOPROTECTOR OF NORMAL BRAIN | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | PHOENIX, AZ-03 | 2024 | $1,487,072 |
ASST_NON_R01ES035388_075 SOUTH AFRICAN MANGANESE ENVIRONMENTAL NEUROTOXIC EFFECTS RESEARCH (SMELTER) - MANGANESE (MN) IS A WELL-ESTABLISHED NEUROTOXICANT THAT LIKELY INDUCES NEURODEGENERATION THROUGH INFL… | Department of Health and Human Services National Institutes of Health | 93.113 ENVIRONMENTAL HEALTH | PHOENIX, AZ-03 | 2024 | $1,170,748 |
ASST_NON_HT94252410426_097 AD GENETIC RISK AS A PROGNOSTIC FACTOR FOR COGNITIVE OUTCOMES AFTER TBI | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2024 | $1,119,598 |
ASST_NON_GE153343_075 COMMUNITY PROJECT FUNDING/CONGRESSIONALLY DIRECTED SPENDING - NON-CONSTRUCTION - THE BARROW NEUROLOGICAL INSTITUTE (BNI) RECENTLY OPENED A STATE-OF-THE-ART DRY LABORATORY SPACE, T… | Department of Health and Human Services Health Resources and Services Administration | 93.493 CONGRESSIONAL DIRECTIVES | PHOENIX, AZ-90 | 2024 | $1,053,000 |
ASST_NON_K23NS101036_075 TRANSLATIONAL ASSESSMENT OF SULFONYLUREA RECEPTOR-1 AS A BIOMARKER AND THERAPEUTIC TARGET FOR CEREBRAL EDEMA IN TRAUMATIC BRAIN INJURY - PROJECT ABSTRACT THERE IS A FUNDAMENTAL GA… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | PHOENIX, AZ-03 | 2024 | $944,297 |
ASST_NON_W81XWH2110144_097 TARGETING CNS EXPRESSION OF CHITINASES AS A NOVEL THERAPY FOR ALS. UPDATES DIVISION I ITEMS A.7 AND A.10.V. 1. EXTENDS THE POP BY 12 MONTHS. TECHNICAL AND FINANCIAL REPORTING SHAL… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2024 | $881,302 |
ASST_NON_R01NS138528_075 ENDOTHELIAL COMPLEMENT C3A RECEPTOR MEDIATED CEREBRAL INJURY IN A MURINE STROKE MODEL. - PROJECT SUM MARY: STROKE IS THE LEADING CAUSE OF ADULT DISABILITY WORLDWIDE. THOUGH INTRAV… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | AZ-90 | 2024 | $853,135 |
ASST_NON_UH3CA247606_075 MULTI-PARAMETRIC PERFUSION MRI FOR THERAPY RESPONSE ASSESSMENT IN BRAIN CANCER - THE LONG-TERM GOAL OF THIS PROGRAM IS TO IMPROVE PATIENT CARE BY OPTIMIZING AND VALIDATING QUANTIT… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | PHOENIX, AZ-03 | 2024 | $812,274 |
ASST_NON_HT94252310206_097 RETINOID-ACTIVATING GENE THERAPY FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS EXTEND THE PERIOD OF PERFORMANCE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2025 | $782,284 |
ASST_NON_HT94252410195_097 THE ROLE OF TDP-43 ASSOCIATED CRYPTIC EXON INCLUSION IN KARLN ON C9ORF72-MEDIATED CORTICAL NEURODEGENERATION | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2024 | $722,545 |
ASST_NON_UG3CA247606_075 MULTI-PARAMETRIC PERFUSION MRI FOR THERAPY RESPONSE ASSESSMENT IN BRAIN CANCER - THE LONG-TERM GOAL OF THIS PROGRAM IS TO IMPROVE PATIENT CARE BY OPTIMIZING AND VALIDATING QUANTIT… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | AZ-90 | 2025 | $712,019 |
ASST_NON_R56AG068630_075 HEMODYNAMIC MECHANISMS LINKING AORTIC ARCH STIFFNESS WITH BRAIN INSULT IN OLDER ADULTS - PROJECT SUMMARY OUR PRIOR STUDIES SUGGEST THAT STIFFENING WITHIN THE AORTIC ARCH (AS QUANT… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | PHOENIX, AZ-03 | 2024 | $709,624 |
ASST_NON_HT94252310352_097 LONGITUDINAL NEUROIMAGING AND MOLECULAR BIOMARKERS OF CEREBROVASCULAR HEALTH IN ALS | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2025 | $707,134 |
ASST_NON_HT94252410625_097 MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE DEVELOPMENT OF NONMOTOR SYMPTOMS IN PARKINSON'S DISEASE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | PHOENIX, AZ-03 | 2024 | $655,380 |
ASST_NON_HT94252410624_097 MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE DEVELOPMENT OF NONMOTOR SYMPTOMS IN PARKINSON'S DISEASE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | PHOENIX, AZ-03 | 2024 | $649,762 |
ASST_NON_W81XWH2010806_097 A MINIATURIZED VALVE THAT MIMICS FUNCTIONAL ARACHNOID GRANULATIONS TO TREAT HYDROCEPHALUS EXTEND THE PERIOD OF PERFORMANCE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2025 | $506,715 |
ASST_NON_R21NS125861_075 ASTROCYTE REGULATION OF CORTICAL NEURODEGENERATION IN C9ORF72 FTD/ALS - PROJECT ABSTRACT THE GGGGCC (G4C2) HEXANUCLEOTIDE REPEAT EXPANSION (HRE) IN THE FIRST INTRON OF THE GENE C… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | PHOENIX, AZ-03 | 2024 | $486,973 |
ASST_NON_R21NS131689_075 A SINGLE CELL AND PROTEOMIC PRECISION MEDICINE APPROACH TO GLYBURIDE RESPONSIVE CONTUSION EXPANSION IN SEVERE TRAUMATIC BRAIN INJURY - FOR DECADES, THERE HAS BEEN A CRITICAL GAP I… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | PHOENIX, AZ-03 | 2024 | $479,542 |
ASST_NON_R21NS128550_075 TRANSCRIPTOMIC ASSESSMENT OF PATHOLOGY IN PD WITH DEMENTIA AND DEMENTIA WITH LEWY BODIES USING IPSC NEURONS AND BRAIN TISSUE OF THE SAME INDIVIDUALS - PROJECT ABSTRACT LEWY BODY… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | PHOENIX, AZ-03 | 2024 | $423,274 |
ASST_NON_R21NS116385_075 NOVEL KNOCK-IN MOUSE MODELS OF ALS AND MYOPATHY-LINKED MATRIN 3 MUTATIONS - PROJECT SUMMARY: THE NUCLEAR PROTEIN MATRIN 3 HAS MANY ROLES IN RNA PROCESSING INCLUDING SPLICING AND… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | PHOENIX, AZ-03 | 2024 | $422,595 |
ASST_NON_R21NS125535_075 INVESTIGATING THE ROLE OF CEREBRAL PERFUSION IN DEMYELINATION AND REPAIR IN MULTIPLE SCLEROSIS WITH MRI - PROJECT SUMMARY / ABSTRACT: MULTIPLE SCLEROSIS IS A CHRONIC, DEBILITATING… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | AZ-90 | 2024 | $421,988 |
ASST_NON_W81XWH2210673_097 RIC THERAPY-MEDIATED NEUROPROTECTION IN EYE TRAUMA EXTEND THE PERIOD OF PERFORMANCE 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 2019, THE US ARMY MEDICAL R… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2024 | $389,476 |
ASST_NON_R21NS130492_075 MECHANISMS OF A-I RNA EDITING-MEDIATED NUCLEAR EXPORT OF TDP-43 - TAR DNA BINDING PROTEIN – 43 (TDP-43) IS A CRITICAL RNA BINDING PROTEIN THAT IS INTIMATELY INVOLVED IN MANY ASPE… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | PHOENIX, AZ-03 | 2024 | $345,566 |
ASST_NON_W81XWH2110672_097 SINGLE-CELL RNA-SEQ AND CLONAL ANALYSIS OF B CELLS IN MS. EXTENDS THE POP BY 12 MONTHS. TECHNICAL AND FINANCIAL REPORTING SHALL CONTINUE IN ACCORDANCE WITH THE AWARD TERMS AND CON… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-11 | 2024 | $236,250 |
ASST_NON_F32DK130535_075 CIRCADIAN REGULATION OF THE DORSOMEDIAL HYPOTHALAMIC NUCLEUS AND ITS IMPACT ON ENERGY HOMEOSTASIS - PROJECT SUMMARY SYSTEMS REGULATING CIRCADIAN TIMING AND ENERGY HOMEOSTASIS ARE… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | AZ-90 | 2024 | $113,010 |
CONT_AWD_36C26223C0161_3600_-NONE-_-NONE- DEOB EXCESS FUNDS | Department of Veterans Affairs Department of Veterans Affairs | — | PHOENIX, AZ-03 | 2024 | $66,264 |
ASST_NON_F31NS139617_075 MICROGLIA- ASTROCYTE CROSSTALK IN CORTICAL NEURODEGENERATION OF C9ORF72 ALS/FTD - PROJECT ABSTRACT AMYOTROPHIC LATERAL SCLEROSIS (ALS) IS A PROGRESSIVE NEURODEGENERATIVE DISEASE… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | AZ-90 | 2025 | $45,724 |
CONT_AWD_VA25817C0044_3600_-NONE-_-NONE- VETERINARY AND ANIMAL RESEARCH SERVICES 52.217-8 OPTION EXTENSION | Department of Veterans Affairs Department of Veterans Affairs | — | PHOENIX, AZ-03 | 2025 | $34,016 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→123456789
93.310 — TRANS-NIH RESEARCH SUPPORT$53.3M
93.866 — AGING RESEARCH$42.0M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$21.4M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$19.3M
93.113 — ENVIRONMENTAL HEALTH$9.2M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$2.2M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$1.6M
93.394 — CANCER DETECTION AND DIAGNOSIS RESEARCH$1.5M
93.493 — CONGRESSIONAL DIRECTIVES$1.1M
Source: USAspending.gov · All Recipients · California